Related Experiment Video
Updated: Aug 14, 2025

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
Aortic valve leaflet disruption techniques in transcatheter aortic valve replacement.
Brian Shin1, David Li1, Hong Liu1
1Department of Anesthesiology and Pain Medicine, University of California Davis Health, Sacramento, USA.
Bioprosthetic or native aortic scallop intentional laceration to prevent iatrogenic coronary artery obstruction (BASILICA) is a novel technique to mitigate coronary artery obstruction during transcatheter aortic valve replacement (TAVR). Patient outcomes following TAVR with BASILICA are promising, expanding TAVR applicability.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Devices
Background:
- Transcatheter aortic valve replacement (TAVR) is a minimally invasive treatment for aortic valve stenosis, expanding treatment options for a broader patient population.
- A significant complication of TAVR is iatrogenic coronary artery obstruction, where displaced native aortic valve leaflets occlude the coronary ostia.
Purpose of the Study:
- To introduce and evaluate the Bioprosthetic or native aortic scallop intentional laceration to prevent iatrogenic coronary artery obstruction (BASILICA) technique.
- To assess the safety and efficacy of BASILICA in preventing coronary artery obstruction during TAVR.
Main Methods:
- The BASILICA technique involves creating a lengthwise laceration of aortic valve leaflets prior to TAVR implantation.
- This procedure aims to prevent the displacement of native leaflets into the coronary artery orifices.
Main Results:
- Patient outcomes following TAVR with the BASILICA technique have demonstrated promising results.
- The technique effectively mitigates the risk of coronary artery obstruction associated with TAVR.
Conclusions:
- BASILICA is a valuable technique for preventing iatrogenic coronary artery obstruction in TAVR procedures.
- Continued refinement and meticulous patient selection are crucial for optimizing TAVR outcomes in high-risk patients.
Related Concept Videos
Mitral Stenosis III: Medical Management
Aortic Regurgitation III: Medical Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation I: Introduction

